about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
21.06
0.31
(1.49%)
66,839.5
XNAS Volume
XNAS 17 Jul, 2026 1:57 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..